Literature DB >> 19124004

CMTM5-v1 induces apoptosis in cervical carcinoma cells.

Luning Shao1, Xiaohuan Guo, Markus Plate, Ting Li, Yu Wang, Dalong Ma, Wenling Han.   

Abstract

CMTM5 (CKLF-like MARVEL transmembrane domain-containing member 5) exhibits tumor inhibition activity with frequent epigenetic inactivation in various tumor cell lines including cervical carcinoma (CC) cells. In this paper, we examined the function of CMTM5-v1 (the primary RNA splicing form) in both HeLa and SiHa cells. Overexpression of CMTM5-v1 in both cells can induce apoptosis, but the effects are more obvious in SiHa than that in HeLa. In SiHa cells, restoration of CMTM5-v1 caused disruption of mitochondrial transmembrane potential, release of cytochrome c, activation of caspase3 and cleavage of PARP. General caspase inhibitor almost prevented apoptosis of SiHa cells, suggesting that CMTM5-v1 induces apoptosis mainly through caspase-dependent pathway. These findings verify that CMTM5-v1 inhibits the growth of CC cell lines via inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124004     DOI: 10.1016/j.bbrc.2008.12.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.

Authors:  Y Xiao; Y Yuan; Y Zhang; J Li; Z Liu; X Zhang; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

2.  Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology.

Authors:  Elham Abedi; Mehran Karimi; Ramin Yaghobi; Hamid Mohammadi; Sezaneh Haghpanah; Mohamad Moghadam; Elahe Bayat; Alireza Rezvani; Mani Ramzi
Journal:  J Clin Lab Anal       Date:  2022-02-17       Impact factor: 2.352

3.  CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.

Authors:  Ting Li; Yingying Cheng; Pingzhang Wang; Wenyan Wang; Fengzhan Hu; Xiaoning Mo; Hongxia Lv; Tao Xu; Wenling Han
Journal:  J Exp Clin Cancer Res       Date:  2015-10-16

4.  CMTM5 inhibits renal cancer cell growth through inducing cell-cycle arrest and apoptosis.

Authors:  Bing Cai; Yunbei Xiao; Yeping Li; Shaobin Zheng
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

Review 5.  CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.

Authors:  Jie Wu; Lan Li; Siyi Wu; Bin Xu
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

6.  CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells.

Authors:  Yeqing Yuan; Zhengzuo Sheng; Zhenhua Liu; Xiaowei Zhang; Yunbei Xiao; Jing Xie; Yixiang Zhang; Tao Xu
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

7.  CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Authors:  Zesong Li; Jun Xie; Jianting Wu; Wenjie Li; Liping Nie; Xiaojuan Sun; Aifa Tang; Xianxin Li; Ren Liu; Hongbing Mei; Feng Wang; Zhiping Wang; Yaoting Gui; Zhiming Cai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  Dipyrithione induces cell-cycle arrest and apoptosis in four cancer cell lines in vitro and inhibits tumor growth in a mouse model.

Authors:  Yumei Fan; Caizhi Liu; Yongmao Huang; Jie Zhang; Linlin Cai; Shengnan Wang; Yongze Zhang; Xianglin Duan; Zhimin Yin
Journal:  BMC Pharmacol Toxicol       Date:  2013-10-21       Impact factor: 2.483

9.  Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.

Authors:  Wanqiong Yuan; Ting Li; Xiaoning Mo; Xiaolin Wang; Baocai Liu; Wenyan Wang; Yu Su; Lan Xu; Wenling Han
Journal:  Oncotarget       Date:  2016-05-17

10.  CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling.

Authors:  Gang Xu; Chengxue Dang
Journal:  Cancer Cell Int       Date:  2017-11-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.